Dear Group Members

This “open class action” was brought by Mr Hayward (“the applicant”) on his own behalf and on behalf of all persons who acquired ordinary shares in the ASX listed company Sirtex Medical Limited (“Sirtex”) on or after 24 August 2016 and who held any of those shares at the commencement of trading on 9 December 2016.

If you are an eligible class member you are not required to do anything to remain a class member in this proceeding.  Unlike other class actions, you are not required to sign any form of legal commitment or usual litigation funding agreement in connection with this proceeding.

The class action has progressed significantly since it was commenced by the applicant on 10 February 2017.

Sirtex has filed and served a defence to the applicant’s statement of claim on 21 July 2017.

The parties have agreed on the necessary security for costs up to and including discovery in the sum of $725,000.00.  The requisite security for costs was posted by the applicant on 31 July 2017.

The parties have agreed categories of documents for discovery by Sirtex.

The proceeding has been listed for trial to commence on 29 April 2019 with a provisional estimate of three weeks.

Thank you for your continued support.

You can contact us for further information by email at